State Street
CPIX icon

State Street’s Cumberland Pharmaceuticals CPIX Stock Holding History

State Street’s Portfolio CPIX Stock Details CPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$256K Hold
39,510
– – ﹤0.01% 3757
2026
Q1 		$128K Buy
39,510
+5,810
+17% +$22.4K ﹤0.01% 3984
2025
Q4 		$134K Hold
33,700
– – ﹤0.01% 3989
2025
Q3 		$105K Hold
33,700
– – ﹤0.01% 4044
2025
Q2 		$113K Hold
33,700
– – ﹤0.01% 3955
2025
Q1 		$143K Hold
33,700
– – ﹤0.01% 3895
2024
Q4 		$79.9K Hold
33,700
– – ﹤0.01% 4036
2024
Q3 		$43.1K Hold
33,700
– – ﹤0.01% 4124
2024
Q2 		$51.6K Hold
33,700
– – ﹤0.01% 4133
2024
Q1 		$56.6K Sell
33,700
-6,090
-15% -$12.1K ﹤0.01% 4135
2023
Q4 		$69.2K Hold
39,790
– – ﹤0.01% 4133
2023
Q3 		$75.2K Sell
39,790
-3,255
-8% -$5.45K ﹤0.01% 4182
2023
Q2 		$63.3K Hold
43,045
– – ﹤0.01% 4355
2023
Q1 		$83.9K Hold
43,045
– – ﹤0.01% 4376
2022
Q4 		$96.9K Hold
43,045
– – ﹤0.01% 4375
2022
Q3 		$104K Hold
43,045
– – ﹤0.01% 4452
2022
Q2 		$89K Buy
43,045
+1,000
+2% +$2.31K ﹤0.01% 4570
2022
Q1 		$119K Sell
42,045
-23,745
-36% -$79K ﹤0.01% 4591
2021
Q4 		$307K Buy
+65,790
New +$224K ﹤0.01% 4178
2018
Q4 		– Sell
-14,044
Closed -$81K – 3768
2018
Q3 		$81K Buy
14,044
+554
+4% +$3.26K ﹤0.01% 3666
2018
Q2 		$82K Buy
13,490
+2,232
+20% +$14K ﹤0.01% 3649
2018
Q1 		$76K Buy
11,258
+1,212
+12% +$8.34K ﹤0.01% 3629
2017
Q4 		$75K Buy
+10,046
New +$73.9K ﹤0.01% 3621
2014
Q3 		– Sell
-11,400
Closed -$51K – 3687
2014
Q2 		$51K Sell
11,400
-1,800
-14% -$8.04K ﹤0.01% 3537
2014
Q1 		$60K Sell
13,200
-1,600
-11% -$7.61K ﹤0.01% 3538
2013
Q4 		$75K Sell
14,800
-4,700
-24% -$22.9K ﹤0.01% 3508
2013
Q3 		$89K Sell
19,500
-2,400
-11% -$11.9K ﹤0.01% 3472
2013
Q2 		$111K Buy
+21,900
New +$109K ﹤0.01% 3378

Other funds holding CPIX

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
B
Bailard Foster City, California $4.91B AUM 31.75% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return

State Street's CPIX Position: Q2 2026 in Review

State Street held its Cumberland Pharmaceuticals (CPIX) position steady in Q2 2026 at 39,510 shares worth $256K. The position accounts for ﹤0.01% of the portfolio, ranked #3757.

State Street first reported a position in CPIX in Q2 2013 and has held it in 28 quarters since. The position peaked at $307K in Q4 2021. 20 funds tracked by Wall St. Rank hold CPIX as of Q2 2026.

  • State Street held 39,510 shares of Cumberland Pharmaceuticals worth $256K as of Q2 2026.
  • State Street left its Cumberland Pharmaceuticals share count unchanged in Q2 2026.
  • Cumberland Pharmaceuticals made up ﹤0.01% of State Street's portfolio in Q2 2026, its #3757 holding.
  • State Street first reported a position in Cumberland Pharmaceuticals in Q2 2013 and has held it in 28 quarters since.
  • State Street's Cumberland Pharmaceuticals position peaked at $307K in Q4 2021.
  • 20 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.